Alexandria Real Estate Gains 19.2% with 1.2M RSF Q4 Leases
Alexandria Real Estate Equities has climbed 19.2% over three months versus the industry's 7.2%, driven by its Class A/A+ life science properties in AAA innovation clusters. In Q4 2025, the REIT executed 1.2 million RSF of leases, placed 139,979 RSF of new development into service and held $5.3 billion liquidity.
1. Stock Performance and Strategic Portfolio
Alexandria Real Estate Equities shares rose 19.2% over the past three months compared to the industry's 7.2% growth, as its Class A/A+ life science properties in key AAA innovation clusters attract demand from AI-driven biotech and pharmaceutical firms requiring large lab footprints.
2. Q4 2025 Leasing and Development
In the fourth quarter of 2025, the REIT executed 1.2 million RSF of new and renewal leases, placed 139,979 RSF of development projects into service and is advancing a 3.5 million RSF pipeline of Class A/A+ properties.
3. Financial Position and Liquidity
The company held $5.3 billion of liquidity at year-end, maintained a net debt plus preferred stock to adjusted EBITDA ratio of 5.7x and a fixed-charge coverage ratio of 3.7x, with a weighted average debt maturity of 12.1 years.
4. Risks and Outlook
Exposure to rising construction costs, potential lease-up delays in its development pipeline and elevated interest expenses could offset leasing momentum, though dispositions of $1.81 billion in non-core assets may fund accretive investments.